Navigation
Latest News
- CYCLOFLUIDIC ANNOUNCE DRUG DISCOVERY AGREEMENT WITH TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE
- Ubiquigent and Cyclofluidic enter into collaboration to build novel Ubiquitin system targeted libraries
- HitGen and Cyclofluidic Collaborate on Lead Development Programme
- MRCT and Cyclofluidic Announce Successful Collaboration
- Cyclofluidic and Sanofi publish results of sucessful technology evaluation
Our Company
At Cyclofluidic we aim to translate our decades of pharma experience and our passion for drug discovery into pre-clinical molecules with the highest chance of becoming innovative medicines We are innovative in both our science and our business; fast and flexible in the way we work to solve medicinal chemistry challenges
We work in true partnership with our collaborators, leveraging the CylOps™ platform to solve medicinal chemistry problems at speed, delivering the highest quality data and results in the shortest possible times with the highest standards of confidentiality.
We are committed to investing in the CylOps™ research platform to provide learning and improvement for all current and future partners.
We are honest and open, respecting our colleagues and partners both internally and in our collaborations
We believe in the newly evolving R&D ecosystem as a great place to do innovative science and support our partners large and small.